News on Mesothelioma | Surviving Mesothelioma

Europe | International | New Studies | Research | Surgery | Treatments

CRS/HIPEC Procedure Has Improved Over Time, Study Finds
ByAlex Strauss April 4, 2021

A new French study contains some good news for people considering the CRS/HIPEC procedure for peritoneal mesothelioma. The CRS/HIPEC procedure…

Read More CRS/HIPEC Procedure Has Improved Over Time, Study Finds
Compensation | Diagnosis | Occupations

Waiting for Medicare Coverage Could Impact Mesothelioma Survival
ByAlex Strauss April 2, 2021

People who suspect they may have cancer but wait to get a diagnosis until they are eligible for Medicare coverage…

Read More Waiting for Medicare Coverage Could Impact Mesothelioma Survival
Surgery | Treatments

Minimally Invasive Surgery for Mesothelioma is “Viable Alternative” to Standard Approaches
ByAlex Strauss March 31, 2021March 31, 2021

A new study from the Icahn School of Medicine at Mount Sinai in New York suggests that minimally invasive surgery…

Read More Minimally Invasive Surgery for Mesothelioma is “Viable Alternative” to Standard Approaches
Diagnosis | Europe | International | Prognosis | Scans

Prognostic Value of PET/CT in Pleural Mesothelioma Patients
ByAlex Strauss March 29, 2021

New data highlights the prognostic value of PET/CT scans for patients with malignant pleural mesothelioma. Pleural mesothelioma is a rare…

Read More Prognostic Value of PET/CT in Pleural Mesothelioma Patients
Chemotherapy | New Studies | Research | Treatments

Real-World Mesothelioma Patients Need New Systemic Treatments
ByAlex Strauss March 28, 2021

The newest study on real-world mesothelioma patients illustrates the need for more ways to treat this devastating cancer. Many studies…

Read More Real-World Mesothelioma Patients Need New Systemic Treatments
Australia | International | Mesothelioma | New Drugs | Treatments

Mesothelioma Clinical Trials: Eligibility May Be Too Strict, Study Finds
ByAlex Strauss March 25, 2021

A new Australian study suggests that too many people are being left out of mesothelioma clinical trials under current trial…

Read More Mesothelioma Clinical Trials: Eligibility May Be Too Strict, Study Finds
Asia | Chemotherapy | International | Treatments

Which Mesothelioma Patients will Benefit from Second-Line Chemotherapy
ByAlex Strauss March 23, 2021

Japanese oncologists say they have found a way to help predict which peritoneal mesothelioma patients are most likely to get…

Read More Which Mesothelioma Patients will Benefit from Second-Line Chemotherapy
Updates

Mesothelioma Case Study: Keytruda Side Effect Treated with Plasma Exchange
ByAlex Strauss March 21, 2021

German mesothelioma doctors say a Keytruda side effect that causes the heart to swell can be treated by “cleaning” the…

Read More Mesothelioma Case Study: Keytruda Side Effect Treated with Plasma Exchange
Diagnosis | Prevention

COVID-19 Fears May Lead to Delayed Mesothelioma Diagnosis
ByAlex Strauss March 20, 2021

Cancer experts are warning that the fear of contracting COVID-19 may result in delayed mesothelioma diagnosis and worse outcomes for…

Read More COVID-19 Fears May Lead to Delayed Mesothelioma Diagnosis
Australia | Chemotherapy | Immunotherapy | International | Treatments

Phase 3 Clinical Trial to Test Durvalumab for Mesothelioma
ByAlex Strauss March 18, 2021

A potential new first-line immunotherapy treatment for mesothelioma is now recruiting patients for a phase 3 clinical trial. The trial…

Read More Phase 3 Clinical Trial to Test Durvalumab for Mesothelioma

1 (888) 378-1331

CRS/HIPEC Procedure Has Improved Over Time, Study Finds

Waiting for Medicare Coverage Could Impact Mesothelioma Survival

Minimally Invasive Surgery for Mesothelioma is “Viable Alternative” to Standard Approaches

Prognostic Value of PET/CT in Pleural Mesothelioma Patients

Real-World Mesothelioma Patients Need New Systemic Treatments

Mesothelioma Clinical Trials: Eligibility May Be Too Strict, Study Finds

Which Mesothelioma Patients will Benefit from Second-Line Chemotherapy

Mesothelioma Case Study: Keytruda Side Effect Treated with Plasma Exchange

COVID-19 Fears May Lead to Delayed Mesothelioma Diagnosis

Phase 3 Clinical Trial to Test Durvalumab for Mesothelioma

United States Sources

Centers for Disease Control and Prevention (CDC), UNITED STATES

Creighton University School of Medicine, UNITED STATES

David Geffen School of Medicine, UCLA, UNITED STATES

Icahn School of Medicine at Mount Sinai, New York, UNITED STATES

Mayo Clinic, UNITED STATES

Moffitt Cancer Center, Tampa, FL, UNITED STATES

National Institute for Occupational Safety & Health, UNITED STATES

University of Chicago, Medical Center, UNITED STATES

University of Maryland School of Medicine, UNITED STATES

University of Hawaii Cancer Center, UNITED STATES

Wake Forest University School of Medicine, UNITED STATES